Director’s Innovation Speaker Series: Beyond FDA Approval: Assessing the Value of New Health Technologies

We're now on Instagram! Follow us @NIMHgov NEWS AND EVENTS Director's Innovation Speaker Series: Beyond FDA Approval: Assessing the Value of New Health Technologies Date/Time: March 8, 2022, 3:00-4:00 p.m. ET Location: Virtual Foluso Agboola, MBBS, MPH will provide a brief background on the Institute for Clinical and Economic Review (ICER) and describe the Value Assessment Framework using their review of esketamine for treatment-resistant depression as an example. Dr. Agboola will also provide examples of how ICER's work is applied in the real world.  Dr. Agboola is the Vice President of Research at ICER. This independent non-profit research institute generates evidence on the effectiveness and value of drugs and other medical services. NIMH established the Director's Innovation Speaker Series to encourage broad, interdisciplinary thinking in the development of scientific initiatives and programs, and to press for theoretical leaps in science over the continuation of incremental thought.  Register for The Lecture

NIMH Science News Questions? Contact NIMH! Director's Messages SUBSCRIBER SERVICES: Manage Preferences  |  Unsubscribe  |  Help

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Mental Health · 6001 Executive Boulevard · Bethesda, MD 20892-9663 · 1-866-615-6464